- Home
- LGHL vs ALLR Comparison
LGHL vs ALLR Comparison
Compare LGHL & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGHL
- ALLR
- Stock Information
- Founded
- LGHL 2015
- ALLR 2004
- Country
- LGHL Singapore
- ALLR United States
- Employees
- LGHL N/A
- ALLR N/A
- Industry
- LGHL Investment Bankers/Brokers/Service
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- LGHL Finance
- ALLR Health Care
- Exchange
- LGHL Nasdaq
- ALLR Nasdaq
- Market Cap
- LGHL 4.3M
- ALLR 6.0M
- IPO Year
- LGHL N/A
- ALLR N/A
- Fundamental
- Price
- LGHL $0.14
- ALLR $1.10
- Analyst Decision
- LGHL
- ALLR
- Analyst Count
- LGHL 0
- ALLR 0
- Target Price
- LGHL N/A
- ALLR N/A
- AVG Volume (30 Days)
- LGHL 2.7M
- ALLR 3.8M
- Earning Date
- LGHL 02-11-2025
- ALLR 03-07-2025
- Dividend Yield
- LGHL N/A
- ALLR N/A
- EPS Growth
- LGHL N/A
- ALLR N/A
- EPS
- LGHL N/A
- ALLR N/A
- Revenue
- LGHL $13,659,110.00
- ALLR N/A
- Revenue This Year
- LGHL N/A
- ALLR N/A
- Revenue Next Year
- LGHL N/A
- ALLR N/A
- P/E Ratio
- LGHL N/A
- ALLR N/A
- Revenue Growth
- LGHL 11.35
- ALLR N/A
- 52 Week Low
- LGHL $0.13
- ALLR $0.90
- 52 Week High
- LGHL $1.55
- ALLR $283.20
- Technical
- Relative Strength Index (RSI)
- LGHL 42.74
- ALLR 42.44
- Support Level
- LGHL $0.14
- ALLR $1.00
- Resistance Level
- LGHL $0.18
- ALLR $1.99
- Average True Range (ATR)
- LGHL 0.02
- ALLR 0.22
- MACD
- LGHL -0.00
- ALLR -0.02
- Stochastic Oscillator
- LGHL 21.49
- ALLR 4.43
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.